Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joke Bilcke

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2018
Case Fatality Rate of Enteric Fever in Endemic Countries: A Systematic Review and Meta-analysisZoë Pieters, Neil J Saad, Marina Antillón, et al.
Plos Medicine|July 17, 2023
The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approachMarina Antillón, Xiao Li, Lander Willem, et al.
BMC Medicine|April 7, 2020
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countriesXiao Li, Lander Willem, Marina Antillon, et al.
Vaccine|September 21, 2014
Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in BelgiumAdriaan Blommaert, Joke Bilcke, Yannick Vandendijck, et al.
Vaccine|March 19, 2016
The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for BelgiumAdriaan Blommaert, Joke Bilcke, Lander Willem, et al.
Vaccine|November 29, 2011
The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United KingdomAlbert Jan van Hoek, Alessia Melegaro, Nigel Gay, et al.
Vaccine|October 4, 2011
Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?Joke Bilcke, Benson Ogunjimi, Frank Hulstaert, et al.
Plos One|June 27, 2009
Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysisJoke Bilcke, Pierre Van Damme, Marc Van Ranst, et al.
European Journal of Pediatrics|March 5, 2008
The health and economic burden of rotavirus disease in BelgiumJoke Bilcke, Pierre Van Damme, Frank De Smet, et al.
The Journal of Infectious Diseases|March 16, 2022
Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian ChildrenXiao Li, Joke Bilcke, Liliana Vázquez Fernández, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2018
Case Fatality Rate of Enteric Fever in Endemic Countries: A Systematic Review and Meta-analysisZoë Pieters, Neil J Saad, Marina Antillón, et al.
Plos Medicine|July 17, 2023
The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approachMarina Antillón, Xiao Li, Lander Willem, et al.
BMC Medicine|April 7, 2020
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countriesXiao Li, Lander Willem, Marina Antillon, et al.
Vaccine|September 21, 2014
Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in BelgiumAdriaan Blommaert, Joke Bilcke, Yannick Vandendijck, et al.
Vaccine|March 19, 2016
The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for BelgiumAdriaan Blommaert, Joke Bilcke, Lander Willem, et al.
Vaccine|November 29, 2011
The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United KingdomAlbert Jan van Hoek, Alessia Melegaro, Nigel Gay, et al.
Vaccine|October 4, 2011
Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?Joke Bilcke, Benson Ogunjimi, Frank Hulstaert, et al.
Plos One|June 27, 2009
Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysisJoke Bilcke, Pierre Van Damme, Marc Van Ranst, et al.
European Journal of Pediatrics|March 5, 2008
The health and economic burden of rotavirus disease in BelgiumJoke Bilcke, Pierre Van Damme, Frank De Smet, et al.
The Journal of Infectious Diseases|March 16, 2022
Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian ChildrenXiao Li, Joke Bilcke, Liliana Vázquez Fernández, et al.
Pageof 6